Currently, patients with high-grade ESS experience earlier and more frequent recurrences and are at a higher risk of death due to the disease.[8] High-dose insulin and dexamethasone combined with radiotherapy provides a novel and promising option for patients with multiple ESS metastases. This evidence concerns the gene INS and endometrioid stromal sarcoma.